• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS FT4 IV; FREE THYROXINE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS FT4 IV; FREE THYROXINE Back to Search Results
Model Number FT4 IV
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 06/30/2023
Event Type  malfunction  
Manufacturer Narrative
This medwatch will cover ft4.Refer to medwatch with a1 patient identifier pt-83281 for information on the tsh results.The analyzer serial number is: (b)(6).The sample was requested for investigation.The investigation is ongoing.
 
Event Description
There was an allegation of questionable elecsys ft4 iv assay results for 1 patient on a cobas e 801 module compared to an abbott analyzer.On (b)(6) 2023, the initial ft4 result was 2.34 ng/ml.On (b)(6) 2023, the sample was sent to another laboratory for testing on an abbott analyzer.The ft4 result was 1.45 ng/dl.The reference ranges were requested but not provided.The abbott results were deemed more in accordance with the patient's clinical picture.
 
Manufacturer Narrative
The patient sample was provided for investigation.It was found that the patient is taking levothyroxine.Per product labeling, "the drugs furosemide, carbamazepine, phenytoin and levothyroxine sodium (l-t4, synthetic levothyroxine 13) caused elevated ft4 recovery at the daily therapeutic concentration." the investigation determined that the ft4 result differences generated between the different methods are consistent with methodological differences.No product problem was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS FT4 IV
Type of Device
FREE THYROXINE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
na
indianapolis, IN 46250
3174767531
MDR Report Key17393822
MDR Text Key320053013
Report Number1823260-2023-02481
Device Sequence Number1
Product Code CEC
UDI-Device Identifier07613336172780
UDI-Public07613336172780
Combination Product (y/n)N
Reporter Country CodeCO
PMA/PMN Number
K220456
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 09/07/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberFT4 IV
Device Catalogue Number09043284190
Device Lot Number67063401
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/06/2023
Initial Date FDA Received07/25/2023
Supplement Dates Manufacturer Received08/24/2023
Supplement Dates FDA Received09/07/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ATORVASTATIN; CALCITRIOL; CITRAGEL; LEVOTHYROXINE; METFORMIN
Patient Age66 YR
Patient SexFemale
-
-